New Delhi, March 23 Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, raised over Rs 122 crore from anchor investors on Monday, a day before its initial public offering (IPO) opens for subscription.Morgan Stanley Asia (Singapore) Pte Ltd, Kotak Lifesciences Fund, Quant...
anchor investors
capital raising
contract development
equity shares
global formulations
hyderabad
india
initial public offering
injectable products
ipo
manufacturingorganization
new delhi
oral solid dosage formulations
pharmaceutical formulation
sai parenteral
